BioNTech SE BNTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:03 PM EDT
208.00quote price arrow up+5.65 (+2.79%)
Volume
122,842
Close
202.35quote price arrow up+18.64 (+10.15%)
Volume
6,689,835
52 week range
45.08 - 213.15

...

Loading . . .
  • Open200.80
  • Day High202.95
  • Day Low184.56
  • Prev Close183.71
  • 52 Week High213.15
  • 52 Week High Date05/04/21
  • 52 Week Low45.08
  • 52 Week Low Date05/14/20

Key Stats

  • Market Cap48.872B
  • Shares Out241.52M
  • 10 Day Average Volume5.36M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change148.22

KEY STATS

  • Open200.80
  • Day High202.95
  • Day Low184.56
  • Prev Close183.71
  • 52 Week High213.15
  • 52 Week High Date05/04/21
  • 52 Week Low45.08
  • 52 Week Low Date05/14/20
  • Market Cap48.872B
  • Shares Out241.52M
  • 10 Day Average Volume5.36M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change148.22

RATIOS/PROFITABILITY

  • EPS (TTM)-0.41
  • P/E (TTM)-497.42
  • Fwd P/E (NTM)7.78
  • EBITDA (MRQ)-53.119M
  • ROE (MRQ)1.63%
  • Revenue (MRQ)586.65M
  • Gross Margin (MRQ)87.70%
  • Net Margin (MRQ)3.15%
  • Debt To Equity (MRQ)17.29%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO4:4004:40
Oppenheimer health care analyst on whether vaccine makers should lose sleep over patent waivers

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
380.46-3.48-0.91%
SGEN
Seagen Inc
135.93-3.56-2.55%
MRNA
Moderna Inc
158.55-4.60-2.82%
GMAB
Genmab A/S
37.24-0.16-0.43%
INCY
Incyte Corp
81.39-1.35-1.63%